I 23 (Glyburide and metformin hydrochloride 2.5 mg / 500 mg)

Pill imprint I 23 has been identified as Glyburide and metformin hydrochloride 2.5 mg / 500 mg.

Glyburide/metformin is used in the treatment of diabetes, type 2 and belongs to the drug class antidiabetic combinations. There is no proven risk in humans during pregnancy. Glyburide/metformin 2.5 mg / 500 mg is not a controlled substance under the Controlled Substance Act (CSA).

Glyburide and metformin hydrochloride

Imprint:

I 23

Strength:

2.5 mg / 500 mg

Color:

Orange

Size:

15.00 mm

Shape:

Elliptical / Oval

Availability:

Prescription only

Drug Class:

Antidiabetic combinations

Pregnancy Category:

B - No proven risk in humans

CSA Schedule:

Not a controlled drug

Manufacturer:

Dr. Reddy’s Laboratories Inc.

National Drug Code (NDC):

55111-0696

Inactive Ingredients:

sodium starch glycolate type A potato
povidone
silicon dioxide
magnesium stearate
hypromellose
magnesium silicate
titanium dioxide
polyethylene glycol 6000
propylene glycol
ferric oxide yellow
ferric oxide red

Other Manufacturers / Repackagers:

NDC Code	Manufacturer / Repackager
23155-0234	Heritage Pharmaceuticals Inc.

Note: Inactive ingredients may vary.

More info Print Imprint Search

Disclaimer: Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Copyright 2016 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.